NEUROPHARMACOLOGY IN THE ELDERLY
Tài liệu tham khảo
Bach, 1981, Disposition of antipyrine and phenytoin correlated with age and liver volume in man, Clin Pharmacokinet, 6, 389, 10.2165/00003088-198106050-00005
Baldessarini, 1996, Drugs and the treatment of psychiatric disorders, 399
Benet, 1996, Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination, 3
Bernus, 1997, Anticonvulsant therapy in aged patients: Clinical pharmacokinetic considerations, Drugs Aging, 10, 278, 10.2165/00002512-199710040-00004
Cadieux, 1989, Drug interactions in the elderly. How multiple drug use increases risk exponentially, Postgrad Med, 86, 179, 10.1080/00325481.1989.11704506
Castleden, 1977, Increased sensitivity to nitrazepam in old age, BMJ, 1, 10, 10.1136/bmj.1.6052.10
Chapron, 1988, Influence of advanced age on drug disposition and response, 107
Chutka, 1995, Symposium on geriatrics—Part I: Drug prescribing for elderly patients [see comments], Mayo Clin Proc, 70, 685, 10.4065/70.7.685
Creasey, 1985, The aging human brain, Ann Neurol, 17, 2, 10.1002/ana.410170103
Irwin, 1992, Principles of neuropharmacology: I. Pharmacokinetics and pharmacodynamics, 1
Johnston, 1992, Fundamentals of drug therapy in neurology, 1
Kaiko, 1982, Narcotics in the elderly, Med Clin North Am, 66, 1079, 10.1016/S0025-7125(16)31383-9
Katzung, 1992, Special aspects of geriatric pharmacology, 862
Lader, 1995, Quality of treatment: What do new antidepressants offer?, Int Clin Psychopharmacol, 10, 5, 10.1097/00004850-199503001-00002
Lang, 1992, Drug-Induced Movement Disorders
Nolan, 1988, Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions, J Am Geriatr Soc, 36, 142, 10.1111/j.1532-5415.1988.tb01785.x
Nutt, 1992, Principles of neuropharmacology: II. Synaptic transmission, 15
Pappert, 1994, Neuroleptic-induced movement disorders: Acute and subacute syndromes, 273
Penney, 1992, Movement disorders, 50
Roth, 1995, Changes in tissue responsiveness to hormones and neurotransmitters during aging, Exp Gerontol, 30, 361, 10.1016/0531-5565(94)00029-3
Salzman, 1985, Geriatric psychopharmacology, Ann Rev Med, 36, 217, 10.1146/annurev.me.36.020185.001245
Salzman, 1982, Key concepts in geriatric psychopharmacology: Altered pharmacokinetics and polypharmacy, Psychiatr Clin North Am, 5, 181, 10.1016/S0193-953X(18)30899-2
Salzman, 1992, Neuropsychopharmacology, 59
Salzman, 1984, Pharmacokinetics of psychotropic drugs and the aging process, 32
Severson, 1984, Neurotransmitter receptors and aging, J Am Geriatr Soc, 32, 24, 10.1111/j.1532-5415.1984.tb05147.x
Smith, 1980, Changes in prevalence, severity, and recovery in tardive dyskinesia with age, Arch Gen Psychiatry, 37, 1368, 10.1001/archpsyc.1980.01780250054006
Spira, 1984, Treatment of agitation and psychosis, 49
Stein, 1994, Avoiding drug reactions: Seven steps to writing safe prescriptions, Geriatrics, 49, 28
Swonger, 1995, Drug Therapy and the Elderly
Theodore, 1990, Clinical pharmacology of antiepileptic drugs: Selected topics, Neurol Clin, 8, 177, 10.1016/S0733-8619(18)30380-3
Woodhouse, 1992, Age-related changes in hepatic function: Implications for drug therapy, Drugs Aging, 2, 243, 10.2165/00002512-199202030-00007
Wynne, 1989, The effect of age upon liver volume and apparent liver blood flow in healthy man, Hepatology, 9, 297, 10.1002/hep.1840090222